INVESTOR RELATIONS
Corporate Profile
At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments.
GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Since the company’s inception in 2003, we have developed a robust, diversified product pipeline.
Volume
4:08 pm EST on Mar 04,2021
Copyright Nasdaq. Minimum 15 minutes delayed.
News
March 4, 2021
March 2, 2021
February 26, 2021
Events
Mar 15, 2021 from 10:00 AM to 11:00 AM EDT
Mar 9, 2021 7:00 AM EST
Mar 3, 2021 from 11:40 AM to 12:40 PM EST